With Wyeth, Pfizer Becomes The Second-largest Multinational Pharma In India
Wyeth India had revenues of $76 million in 2008 from products such as Enbrel, Rapamune, Prevenar and Tygacil.
Wyeth India had revenues of $76 million in 2008 from products such as Enbrel, Rapamune, Prevenar and Tygacil.